Brazil Human Embryonic Stem Cells Market Size & Outlook
Brazil human embryonic stem cells market, 2018-2030 (US$M)
Related Markets
Brazil human embryonic stem cells market highlights
- The Brazil human embryonic stem cells market generated a revenue of USD 33.6 million in 2023 and is expected to reach USD 68.1 million by 2030.
- The Brazil market is expected to grow at a CAGR of 10.6% from 2024 to 2030.
- In terms of segment, regenerative medicine was the largest revenue generating application in 2023.
- Drug Discovery & Development is the most lucrative application segment registering the fastest growth during the forecast period.
Human embryonic stem cells market data book summary
| Market revenue in 2023 | USD 33.6 million |
| Market revenue in 2030 | USD 68.1 million |
| Growth rate | 10.6% (CAGR from 2023 to 2030) |
| Largest segment | Regenerative medicine |
| Fastest growing segment | Drug Discovery & Development |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Regenerative Medicine, Drug Discovery & Development |
| Key market players worldwide | Thermo Fisher Scientific Inc, Sartorius Stedim Biotech SA, Element Solutions Inc, PromoCell GmbH, Lonza Group Ltd, LifeCell International, Gilead Sciences Inc, International Stem Cell Corp |
Other key industry trends
- In terms of revenue, Brazil accounted for 2.4% of the global human embryonic stem cells market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Latin America, Brazil human embryonic stem cells market is projected to lead the regional market in terms of revenue in 2030.
- Mexico is the fastest growing regional market in Latin America and is projected to reach USD 34.1 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Human Embryonic Stem Cells Market Scope
Human Embryonic Stem Cells Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Brazil human embryonic stem cells market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to human embryonic stem cells market will help companies and investors design strategic landscapes.
Regenerative medicine was the largest segment with a revenue share of 90.48% in 2023. Horizon Databook has segmented the Brazil human embryonic stem cells market based on regenerative medicine, drug discovery & development covering the revenue growth of each sub-segment from 2018 to 2030.
The embryonic stem cell research was regulated in Brazil by The Biosafety Act of 2005. In May 2016, the Federal Government created new rules for the Genetic Heritage Access Law.
With the compliance of this law, the government enabled accession to genetic heritage and protection of the associated traditional knowledge to provide benefit-sharing for sustainable use and conservation of diversity in the country.
Although the law has been revised making embryonic stem cell research legal by allowing the use of stem cells from frozen embryos left over from in-vitro fertilization but it does not allow the cloning of stem cells even for therapeutic purposes.
Reasons to subscribe to Brazil human embryonic stem cells market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Brazil human embryonic stem cells market databook
-
Our clientele includes a mix of human embryonic stem cells market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Brazil human embryonic stem cells market , including forecasts for subscribers. This country databook contains high-level insights into Brazil human embryonic stem cells market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Brazil human embryonic stem cells market size, by application, 2018-2030 (US$M)
Brazil Human Embryonic Stem Cells Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
